Publicaciones (29) Publicaciones de Carmen Vicente Vázquez

2023

  1. Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation

    Blood, Vol. 141, Núm. 9, pp. 1047-1059

  2. Regulation and role of the PP2A-B56 holoenzyme family in cancer

    Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1878, Núm. 5

  3. Set Protein Is Involved in FLT3 Membrane Trafficking

    Cancers, Vol. 15, Núm. 8

2021

  1. Endogenous retroelement activation by epigenetic therapy reverses the warburg effect and elicits mitochondrial-mediated cancer cell death

    Cancer Discovery, Vol. 11, Núm. 5, pp. 1268-1285

2020

  1. A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia

    Blood Cancer Journal, Vol. 10, Núm. 1

  2. A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity

    Cancer Letters, Vol. 468, pp. 1-13

2019

  1. Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia

    Blood, Vol. 134, Núm. 16, pp. 1323-1336

2018

  1. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system

    Leukemia, Vol. 32, Núm. 4, pp. 941-951

  2. HOXA9 cooperates with activated JAK/STAT signaling to drive leukemia development

    Cancer Discovery, Vol. 8, Núm. 5, pp. 616-631

  3. The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models

    Journal of Hematology and Oncology, Vol. 11, Núm. 1

  4. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling

    Leukemia, Vol. 32, Núm. 3, pp. 809-819

2017

  1. The genetics and molecular biology of T-ALL

    Blood, Vol. 129, Núm. 9, pp. 1113-1123

2016

  1. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia

    Haematologica, Vol. 101, Núm. 8, pp. 951-958

  2. Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors

    Blood, Vol. 128, Núm. 23, pp. 2642-2654

2015

  1. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia

    Haematologica, Vol. 100, Núm. 10, pp. 1301-1310

  2. The genomic landscape of adult T cell leukemia/lymphoma

    Nature Genetics

  3. The origin of relapse in pediatric T-cell acute lymphoblastic leukemia

    Haematologica

2014

  1. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. BMI1, The polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma

    Genes Chromosomes and Cancer, Vol. 52, Núm. 10, pp. 928-944

  2. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia

    Nature Genetics, Vol. 45, Núm. 2, pp. 186-190